Acro Biomedical (ACBM) Accumulated Expenses (2021 - 2022)
Acro Biomedical (ACBM) recorded quarterly Accumulated Expenses of $19.8 million in Q1 2022, down 16.52% quarter-over-quarter from $23.8 million in Q4 2021.
Acro Biomedical (ACBM) Accumulated Expenses (2021 - 2022) Analysis & Trends
Acro Biomedical's Accumulated Expenses history runs 2 years deep, the most recent figure standing at $19.8 million for Q1 2022.
- In Q1 2022, Accumulated Expenses changed N/A year-over-year to $19.8 million; the TTM figure through Mar 2022 stood at $19.8 million (changed N/A YoY), while the FY2021 annual figure was $23.8 million, changed N/A from the prior year.
- Accumulated Expenses was $19.8 million for Q1 2022 at Acro Biomedical, down from $23.8 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $23.8 million in Q4 2021 to a low of $18.5 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 19.85 Mn |
| Dec 31, 2021 | 23.77 Mn |
| Jun 30, 2021 | 18.51 Mn |